Literature DB >> 10852971

v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.

T Akagi1, T Shishido, K Murata, H Hanafusa.   

Abstract

v-Crk induces cellular tyrosine phosphorylation and transformation of chicken embryo fibroblasts (CEF). We studied the molecular mechanism of the v-Crk-induced transformation. Experiments with Src homology (SH)2 and SH3 domain mutants revealed that the induction of tyrosine phosphorylation of cellular proteins requires only the SH2 domain, but both the SH2 and SH3 domains are required for complete transformation. Analysis of three well defined signaling pathways, the mitogen-activated protein kinase (MAPK) pathway, the Jun N-terminal kinase (JNK) pathway, and the phosphoinositide 3-kinase (PI3K)/AKT pathway, demonstrated that only the PI3K/AKT pathway is constitutively activated in v-Crk-transformed CEF. Both the SH2 and SH3 domains are required for this activation of the PI3K/AKT pathway in CEF. We also found that the colony formation of CEF is strongly induced by a constitutively active PI3K mutant, and that a PI3K inhibitor, LY294002, suppresses the v-Crk-induced transformation. These results strongly suggest that constitutive activation of the PI3K/AKT pathway plays an essential role in v-Crk-induced transformation of CEF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852971      PMCID: PMC16538          DOI: 10.1073/pnas.140210297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Cellular survival: a play in three Akts.

Authors:  S R Datta; A Brunet; M E Greenberg
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

2.  Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.

Authors:  M Matsuda; C T Reichman; H Hanafusa
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.

Authors:  B J Mayer; H Hanafusa
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Morphometric and colorimetric analyses of human tumor cell line growth and drug sensitivity in soft agar culture.

Authors:  M C Alley; C M Pacula-Cox; M L Hursey; L R Rubinstein; M R Boyd
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

5.  Phosphatidylinositol kinase type I activity associates with various oncogene products.

Authors:  Y Fukui; S Kornbluth; S M Jong; L H Wang; H Hanafusa
Journal:  Oncogene Res       Date:  1989

6.  Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA.

Authors:  L J Chang; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

7.  A novel viral oncogene with structural similarity to phospholipase C.

Authors:  B J Mayer; M Hamaguchi; H Hanafusa
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

8.  Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.

Authors:  W M Potts; M Olsen; D Boettiger; V M Vogt
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

9.  Rapid transformation of cells by Rous sarcoma virus.

Authors:  H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

10.  Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.

Authors:  E Penuel; G S Martin
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

View more
  49 in total

1.  Localization of the PP2A B56gamma regulatory subunit at the Golgi complex: possible role in vesicle transport and migration.

Authors:  Akihiko Ito; Yu-ichiro Koma; Miwa Sohda; Kenji Watabe; Teruaki Nagano; Yoshio Misumi; Hiroshi Nojima; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation.

Authors:  Wataru Kamitani; Krishna Narayanan; Cheng Huang; Kumari Lokugamage; Tetsuro Ikegami; Naoto Ito; Hideyuki Kubo; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

4.  Suppression of viral replication by stress-inducible GADD34 protein via the mammalian serine/threonine protein kinase mTOR pathway.

Authors:  Kahori Minami; Yukihiro Tambe; Ryosuke Watanabe; Takahiro Isono; Masataka Haneda; Ken-Ichi Isobe; Toshiyuki Kobayashi; Okio Hino; Hidetoshi Okabe; Tokuhiro Chano; Hirokazu Inoue
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

5.  Involvement of syntaxin 18, an endoplasmic reticulum (ER)-localized SNARE protein, in ER-mediated phagocytosis.

Authors:  Kiyotaka Hatsuzawa; Taku Tamura; Hitoshi Hashimoto; Hiromi Hashimoto; Sachihiko Yokoya; Megumi Miura; Hisao Nagaya; Ikuo Wada
Journal:  Mol Biol Cell       Date:  2006-06-21       Impact factor: 4.138

6.  A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.

Authors:  James Schuman; Yuhong Chen; Andrew Podd; Mei Yu; Hong-Hsing Liu; Renren Wen; Zhijian J Chen; Demin Wang
Journal:  Blood       Date:  2009-02-05       Impact factor: 22.113

7.  Crk adaptor proteins mediate actin-dependent T cell migration and mechanosensing induced by the integrin LFA-1.

Authors:  Nathan H Roy; Joanna L MacKay; Tanner F Robertson; Daniel A Hammer; Janis K Burkhardt
Journal:  Sci Signal       Date:  2018-12-11       Impact factor: 8.192

8.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.

Authors:  Tsuyoshi Akagi; Kazutaka Murata; Tomoyuki Shishido; Hidesaburo Hanafusa
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Authors:  Raymond B Birge; Charalampos Kalodimos; Fuyuhiko Inagaki; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2009-05-10       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.